These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4852505)
21. [Comparative studies on the effectiveness of vitamin K1 and vitamin K2]. Yasunaga K Naika Hokan; 1970 Sep; 17(9):279-83. PubMed ID: 5531458 [No Abstract] [Full Text] [Related]
22. Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism. Self T; Weisburst M; Wooten E; Straughn A; Oliver J JAMA; 1975 Mar; 231(11):1165-6. PubMed ID: 1172818 [No Abstract] [Full Text] [Related]
23. Interaction of commonly prescribed drugs and warfarin. Robinson DS; Sylwester D Ann Intern Med; 1970 Jun; 72(6):853-6. PubMed ID: 5448744 [No Abstract] [Full Text] [Related]
24. [Interaction of rifampicin with phenprocoumon (author's transl)]. Held H Dtsch Med Wochenschr; 1979 Sep; 104(37):1311-4. PubMed ID: 477551 [TBL] [Abstract][Full Text] [Related]
25. Antagonism of the anti-thrombotic effect of warfarin by uric acid. Newland H Am J Med Sci; 1968 Jul; 256(1):44-52. PubMed ID: 5664331 [No Abstract] [Full Text] [Related]
26. Pharmacokinetics of warfarin following intravenous administration to man. O'Reilly RA; Welling PG; Wagner JG Thromb Diath Haemorrh; 1971; 25(1):178-86. PubMed ID: 5577970 [No Abstract] [Full Text] [Related]
27. Stereoselective interaction between the R enantiomer of warfarin and cimetidine. Choonara IA; Cholerton S; Haynes BP; Breckenridge AM; Park BK Br J Clin Pharmacol; 1986 Mar; 21(3):271-7. PubMed ID: 2938614 [TBL] [Abstract][Full Text] [Related]
28. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0. Denas G; Cucchini U; Iliceto S; Pengo V Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831 [No Abstract] [Full Text] [Related]
29. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. Andreasen PB; Vesell ES Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464 [No Abstract] [Full Text] [Related]
30. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766. Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504 [TBL] [Abstract][Full Text] [Related]
32. Warfarin therapy not influenced by meprobamate. A controlled study in nine men. Udall JA Curr Ther Res Clin Exp; 1970 Nov; 12(11):724-8. PubMed ID: 4993125 [No Abstract] [Full Text] [Related]
33. Letter: Increased warfarin requirement during mercaptopurine therapy: a new drug interaction. Spiers AS; Mibashan RS Lancet; 1974 Jul; 2(7874):221-2. PubMed ID: 4135641 [No Abstract] [Full Text] [Related]
34. The distribution of warfarin (Coumadin) in the rat. Anderson GF Thromb Diath Haemorrh; 1967 Dec; 18(3-4):754-8. PubMed ID: 5590254 [No Abstract] [Full Text] [Related]
35. Warfarin revisited. Deykin D N Engl J Med; 1970 Jun; 282(26):1486. PubMed ID: 5419298 [No Abstract] [Full Text] [Related]
36. Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols. Lewis RJ; Trager WF; Robinson AJ; Chan KK J Lab Clin Med; 1973 Jun; 81(6):925-31. PubMed ID: 4710371 [No Abstract] [Full Text] [Related]
37. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin. Martini A; Jähnchen E J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594 [TBL] [Abstract][Full Text] [Related]
38. The stereoselective interaction of warfarin and metronidazole in man. O'Reilly RA N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223 [TBL] [Abstract][Full Text] [Related]
39. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. Sellers EM; Koch-Weser J N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032 [No Abstract] [Full Text] [Related]
40. Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin. Van Hecken A; De Lepeleire I; Verbesselt R; Arnout J; Angehrn J; Youngberg C; De Schepper PJ Int J Clin Pharmacol Res; 1988; 8(5):315-9. PubMed ID: 3229872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]